Assistant Professor, Radiology, University of Pittsburgh School of Medicine
Psychiatry
Dr. Rajesh Narendran, MD
|
|
Give Review
Rajesh Narendran practices Psychiatry. Rajesh Narendran, MD is a published doctor and has 38 publications published. The lastest was: 'Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates.'
Publications
- Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates.
- Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [(11)C]FLB 457 PET study.
- Improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated Fatty Acid supplementation.
- Prefrontal response and frontostriatal functional connectivity to monetary reward in abstinent alcohol-dependent young adults.
- Reproducibility of post-amphetamine [11C]FLB 457 binding to cortical D2/3 receptors.
- In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers.
- Imaging of dopamine D(2/3) agonist binding in cocaine dependence: a [(11) C]NPA positron emission tomography study.
- Amphetamine induced dopamine release increases anxiety in individuals recovered from anorexia nervosa.
- Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).
- Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopam...
- Imaging neurotransmitter release by drugs of abuse.
- No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortex.
- Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studies.
- A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopa...
- Dopamine type 2/3 receptor availability in the striatum and social status in human volunteers.
- Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion.
- Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET.
- Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation a...
- Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotrac...
- Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine.
- Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature.
- Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects.
- Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.
- Three-hundred-sixty degree barrier effect of a square-edged and an enhanced-edge intraocular lens on centripetal lens epithelial cell migration Two-year results.
- Amphetamine-induced dopamine release: duration of action as assessed with the D2/3 receptor agonist radiotracer (-)-N-[(11)C]propyl-norapomorphine ([11C]NPA) in an ane...
- Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
- Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods.
- Altered prefrontal dopaminergic function in chronic recreational ketamine users.
- Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.
- Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission to...
- Measurement of the proportion of D2 receptors configured in state of high affinity for agonists in vivo: a positron emission tomography study using [11C]N-propyl-norap...
- Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.
- In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 ...
- Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates.
- Who are patients on conventional antipsychotics?
- Efficacy of clozapine in the treatment of atypical antipsychotic refractory schizophrenia: a pilot study.
- Is psychosis exacerbated by modafinil?
Doctors Specialties
- Psychiatry
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. Leonid S. Krimer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maurice S. Cerul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawson F. Bernstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Claire M. Cohen, MD |
|
|
Dr. Edward S. Friedman, MD |
|
|
Dr. Robin E. Berlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen A. Kelly, MD |
|
|
Dr. Eric D. Rickin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert W. Staley, MD |
|
|
Dr. Matthew Lang, DO |
|
|
Dr. Lawson F. Berstein, MD |
|
|
Dr. Amy Kelly, MD |
|
|
Dr. Jason B. Rosenstock, MD
This Doctor is OpenDoctor Recommended.
|